Collegium Pharmaceutical, Inc.COLLNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$203.33M
↑ 384% above average
Average (9y)
$42.04M
Historical baseline
Range
High:$274.29M
Low:$-279.83M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $203.33M | -25.9% |
| 2023 | $274.29M | +123.7% |
| 2022 | $122.61M | +20.7% |
| 2021 | $101.61M | +136.3% |
| 2020 | $-279.83M | -1411.0% |
| 2019 | $21.34M | -85.3% |
| 2018 | $145.04M | +313.3% |
| 2017 | $-68.01M | +12.8% |
| 2016 | $-78.03M | -255.8% |
| 2015 | $-21.93M | - |